Healthcare | April 02, 2024
Vivity reaches 1 million milestone
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
The company had earlier announced about the approval received from the MHRA for Liraglutide
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
The facility will manufacture tablets, capsules, and injections for the oncology segment
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Subscribe To Our Newsletter & Stay Updated
